The content on this site is intended for healthcare professionals only
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
4 Nov 2020
Updates in geriatric medical oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
28 Oct 2020
OncoAlert and ecancer weekly roundup for August 17-23 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
24 Aug 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Aug 2020
CaRE2 Cancer Research Link© : Pancreatic Cancer Disparities featuring Prof Jose ...
Prof Folakemi Odedina and Prof Jose Trevino
11 Aug 2020
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as fi...
Prof Bruno Sangro - University of Navarra, Pamplona, Spain
15 Jul 2020
Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal aden...
Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA
8 Jul 2020
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into live...
Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, US...
17 Jun 2020
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for re...
Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA
15 Jun 2020
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
12 Jun 2020
Highlights from ASCO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
5 Jun 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
22 Apr 2020
